You're reading the free version. Trader adds the live tape and alerts.
Start tracking
QNRX Buy Disclosure
Myers Michael · SEC Form 4 · Filed Sep 1, 2026
Buy
Reported value range
Not reported
Myers Michael Chief Executive Officer
QNRX
Transaction date
Aug 31, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed 1 day later
QNRX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Ordinary Warrants (Right to Buy) on ADS
- Quantity / price
- 10,245 shares
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001104659-26-104404
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$99.99K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Quoin Pharmaceuticals, Ltd. QNRX | Buy | Aug 31, 2026 | $99.99K |
| Quoin Pharmaceuticals, Ltd. QNRX Current | Buy | Aug 31, 2026 | Not reported |